Verified Events
DateTypeCompanyHeadlineSegment
Wandercraft completes acquisition of Ekso Bionics operating business
- Atalante X and EksoNR together support patients at more than 700 rehabilitation centers worldwide.
- Wandercraft intends to keep supporting Atalante X, EksoNR, Eve and Indego Personal.
- Both boards unanimously approved the transaction, combining Wandercraft’s EMEA position with Ekso’s U.S. clinical and commercial reach.